
Loading, please wait...

Loading, please wait...

Addressing disparities in patient outcomes requires precise tools and strategic evaluation. A recent study by Alexander CS et al. introduces a Pharmacy Health Equity Scorecard to help clinic-based pharmacists evaluate their contribution to health equity. Traditionally, pharmacists have lacked standardized metrics to demonstrate how their clinical interventions reduce gaps in care. This new framework aims to bridge that gap by providing a reproducible process for indicator selection. Consequently, healthcare systems can now better quantify the value pharmacists bring to underserved populations.
The research team employed a modified Delphi methodology to ensure the validity of the selected indicators. Initially, they conducted an environmental scan to identify potential metrics. Following this, twenty subject matter experts (SMEs) evaluated these indicators based on importance, usability, and validity. The process involved two iterative survey rounds and a final consensus meeting. Although twenty experts were recruited, participation remained high throughout the rounds. Ultimately, the experts reached a consensus on eight primary health indicators that will form the core of the scorecard.
Clinical pharmacists in ambulatory settings are uniquely positioned to address social determinants of health. Moreover, they often manage chronic conditions such as diabetes and hypertension, where equity gaps are most prominent. By utilizing a standardized
The scorecard provides a standardized tool to evaluate how clinic-based pharmacists impact health equity. It helps identify specific areas where pharmacists successfully close care gaps for marginalized populations.
Researchers used a modified Delphi method involving subject matter experts. These experts reviewed potential indicators for their clinical relevance, ease of use, and scientific validity through multiple rounds of surveys.
Ambulatory care pharmacists often provide long-term management for chronic diseases. This tool allows them to objectively demonstrate their value in improving outcomes for diverse patient groups and reducing systemic disparities.
Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pharmacist, or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Alexander CS et al. Identification of health indicators for a health equity scorecard in ambulatory care pharmacy practice. Am J Health Syst Pharm. 2026 Apr 05. doi: undefined. PMID: 41935381.
2. Traynor K. Bridging health disparities: a national survey of ambulatory care pharmacists in underserved areas. Am J Health-Syst Pharm. 2021;78(17):1551-1554.
3. Smith M, et al. The role of clinical pharmacists in achieving health equity. Journal of the American College of Clinical Pharmacy. 2022;5(4):450-460.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Experts have identified 8 key health indicators for a new scorecard designed to measure the impact of clinic-based pharmacists on health equity....
6 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday